PBM Capital Group Invests in Xalud Therapeutics

By | Uncategorized | No Comments

Gene Therapy Platform for Treatment of Neuro-Inflammatory Diseases June 25, 2015 08:00 AM Eastern Daylight Time CHARLOTTESVILLE, VA–(BUSINESS WIRE)—PBM Capital Group, a healthcare-focused private investment firm, announces an investment in Xalud Therapeutics (www.xaludthera.com). This round of financing will help support the company’s gene therapy platform targeting multiple neuro-inflammatory…

Read More

Research on activating Glial Cells to be presented at 7th Annual Pain Therapeutics Summit East

By | Press Release | No Comments

July 11, 2013, News Medical – Linda Watkins, Ph.D., Distinguished Professor, Department of Psychology & Neuroscience and Center for Neuroscience, University of Colorado, Co-Chair, Advisory Board, Xalud Therapeutics, Inc. will present research on activating Glial Cells as part of the speaking faculty at the 7th Annual Pain Therapeutics…

Read More